 anti-b-cel monoclon antibodi treatment sever b-cell lymphoprolif syndrom bone marrow organ transplant background b-cell lymphoprolif syndrom infrequ life-threaten complic marrow organ transplant consequ profound immunosuppress result treatment disappoint small number patient chemoradiotherapi antivir agent reduct dosag immunosuppress therapi result disord anti-b-cel antibodi method twenty-six patient aggress b-cell lymphoprolif syndrom bone marrow organ transplant mg antibodi kilogram bodi weight consecut day open prospect multicent trial result treatment patient transient molecul granulocyt treatment ineffect patient monoclon b-cell prolifer contrast patient oligoclon b-cell prolifer complet remiss system remiss patient oligoclon prolifer central nervou system involv progress central nervou system diseas patient clonal patient complet remiss persist immunodefici due marrow reject acut graft-versus-host diseas relaps graft-versus-host diseas eleven patient aliv disease-fre median follow-up month marrow recipi organ recipi patient complet remiss unrel caus month treatment conclus intraven administr anti-b-cel antibodi effect diffus sever oligoclon b-cell prolifer central nervou system